Helen Saunders1, Laura de la Fuente Bitaine2, Chriss Eftekhar3, Colin M Howles4, Johanna Glaser5, Tina Hoja5, Pablo Arriagada1. 1. a Medical Affairs , PregLem/Gedeon Richter , Geneva , Switzerland. 2. b Medical Affairs , Servicio de Obstetricia y Ginecología del Hospital Doce de Octubre (Obstetrics and Gynaecology Service of Hospital Doce de Octubre) , Madrid , Spain. 3. c Head of Nursing , St Pauls & Wimbledon, CREATE Fertility , London. 4. d Consultant Medical Affairs Fertility Division , PregLem/Gedeon Richter , Geneva , Switzerland. 5. e Marketing Research & Consultancy GmbH , Point-Blank International , Berlin , Germany.
Abstract
OBJECTIVE: The main objective of this user experience testing study was to evaluate the impact of human factors on the use of a disposable pen containing follitropin alfa by patients and nurses with special focus on the convenience, safety and ease of use, in different types of stimulation protocols. METHODS: Infertile women trying to conceive, and specialist nurses were recruited across 6 European countries. In total 18 patients and 19 nurses took part in the testing, which included both nurse-patient pairings and in-depth interviews. A standardized list of expected and pre-defined critical steps according to the Instructions for Use (IFU), was used to assess the correct handling of the pen. RESULTS: During the user experience testing, no critical errors, related to the use of the pen, which could affect the success of the injection process were identified. In general, both nurses and patients found the pen very easy to learn, use and would be confident using the pen for self-injection. Nurses also found the pen very easy to train the patients. CONCLUSIONS: The study provides valuable information on the pen from both patient and nurse perspectives in different simulated scenarios reflecting standard practice.
OBJECTIVE: The main objective of this user experience testing study was to evaluate the impact of human factors on the use of a disposable pen containing follitropin alfa by patients and nurses with special focus on the convenience, safety and ease of use, in different types of stimulation protocols. METHODS: Infertile women trying to conceive, and specialist nurses were recruited across 6 European countries. In total 18 patients and 19 nurses took part in the testing, which included both nurse-patient pairings and in-depth interviews. A standardized list of expected and pre-defined critical steps according to the Instructions for Use (IFU), was used to assess the correct handling of the pen. RESULTS: During the user experience testing, no critical errors, related to the use of the pen, which could affect the success of the injection process were identified. In general, both nurses and patients found the pen very easy to learn, use and would be confident using the pen for self-injection. Nurses also found the pen very easy to train the patients. CONCLUSIONS: The study provides valuable information on the pen from both patient and nurse perspectives in different simulated scenarios reflecting standard practice.
Entities:
Keywords:
Follitropin α; human factors; in vitro fertilization; infertility; pen injector; recombinant human follicle stimulating hormone; user experience